Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis
Authors Xiong GS, Li LY, Chen XB, Song SN, Zhao YP, Cai WK, Peng JP
Received 1 August 2018
Accepted for publication 19 December 2018
Published 12 February 2019 Volume 2019:12 Pages 1171—1180
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 2
Editor who approved publication: Dr Leo Jen-Liang Su
Guosheng Xiong,1,* Liyin Li,2,* Xiaobo Chen,1 Sinuo Song,3 Yunping Zhao,1 Wenke Cai,4 Jingping Peng4
1Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, People’s Republic of China; 2Department of Hematology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, People’s Republic of China; 3Department of Medical Management, Kunming General Hospital, Kunming, Yunnan 650032, People’s Republic of China; 4Department of Cardiovascular and Thoracic, Kunming General Hospital, Kunming, Yunnan 650032, People’s Republic of China
*These authors contributed equally to this work
Aim: The purpose of this study is to consider the function of cytoskeleton-associated protein 2-like (CKAP2L) in lung adenocarcinoma (LAD) development and its prognostic value.
Methods: The mRNA expression of CKAP2L and its correlation with clinical factors in LAD patients were analyzed from the data taken from The Cancer Genome Atlas and The First Affiliated Hospital of Kunming Medical University. We constructed H460 and A549 cell lines with silenced CKAP2L using RNA interference. Cell counting kit-8 assay and colony formation assays were carried out to determine the function of CKAP2L in H460 and A549 cell proliferation. Transwell and wound healing assays were applied to determine the effect of CKAP2L on H460 and A549 cell invasion and migration. The influences of CKAP2L on mitogen-activated protein kinase signaling pathway-related proteins were tested by Western blotting.
Results: CKAP2L expression is enhanced in LAD tissues and is predictive of poor prognosis in LAD patients. High expression of CKAP2L is associated with stage (P<0.001), lymph node status (P=0.002), and metastasis (P=0.025). Depletion of CKAP2L dramatically suppressed the proliferation, migration, and invasion of H460 and A549 cells. Moreover, the ratio of p-MEK/MEK and p-ERK/ERK reduced obviously in A549 cells after depleting CKAP2L.
Conclusion: Our findings implied that CKAP2L might be a promoter of LAD and could serve as a predictor for LAD patients.
Keywords: CKAP2L, prognosis, lung adenocarcinoma, migration, proliferation
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]